Wide Ranks

MRKR

Marker Therapeutics, Inc.

3.19

Top Statistics
Market Cap 28 M Forward PE -1.46 Revenue Growth 53.30 %
Current Ratio 5.92 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -278.22 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue 5.26 Price To Sales Trailing12 Months 7.64
Profitability
Profit Margins -278.22 % Operating Margins -197.40 %
Balance Sheet
Total Cash 7 M Total Cash Per Share 0.8740 Total Debt
Total Debt To Equity Current Ratio 5.92 Book Value Per Share 1.58
All Measures
Short Ratio 155.00 % Message Board Id finmb_1725474 Shares Short Prior Month 55784
Return On Equity -0.7174 City Houston Uuid f52316f7-d523-378a-bebe-a89c89d1c289
Previous Close 3.26 First Trade Date Epoch Utc 1 B Book Value 1.58
Beta 1.49 Volume 11764 Price To Book 2.02
Last Split Date 1 B Fifty Two Week Low 2.44 Total Cash Per Share 0.8740
Total Revenue 3 M Shares Short Previous Month Date 1 B Target Median Price 19.00
Max Age 86400 Recommendation Mean 1.00 Sand P52 Week Change 0.3133
Operating Margins -197.40 % Target Mean Price 19.00 Net Income To Common -10307587
Short Percent Of Float 0.0109 Implied Shares Outstanding 9 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 31160 Average Volume10days 31160
Total Cash 7 M Next Fiscal Year End 1 B Revenue Per Share 0.4200
Held Percent Insiders 0.1220 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 3.26 Target Low Price 19.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 3.33 Open 3.21
Free Cashflow -7401172 State TX Dividend Yield 0.00 %
Return On Assets -0.4087 Time Zone Short Name EST Trailing Eps -1.07
Day Low 3.13 Address1 9350 Kirby Drive Shares Outstanding 8 M
Price Hint 4 Target High Price 19.00 Website https://markertherapeutics.com
52 Week Change 0.1558 Average Volume 36496 Forward Eps -1.46
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 521.80 %
Last Split Factor 1:10 Regular Market Day High 3.49 Is_sp_500 False
Profit Margins -278.22 % Fifty Two Week High 6.16 Day High 3.49
Shares Short 69997 Regular Market Open 3.21 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 5.26 Revenue Growth 53.30 %
Shares Percent Shares Out 0.0078 Operating Cashflow -10899731 Currency USD
Time Zone Full Name America/New_York Market Cap 28 M Is_nasdaq_100 False
Zip 77054 Quote Type EQUITY Industry Biotechnology
Long Name Marker Therapeutics, Inc. Regular Market Day Low 3.13 Held Percent Institutions 0.2244
Current Price 3.19 Address2 Suite 300 Financial Currency USD
Current Ratio 5.92 Gross Margins -156.82 % Industry Disp Biotechnology
Number Of Analyst Opinions 1 Country United States Float Shares 6 M
Two Hundred Day Average 3.97 Enterprise Value 19 M Price To Sales Trailing12 Months 7.64
Forward PE -1.46 Regular Market Volume 11764 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens.

The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer.

Marker Therapeutics, Inc. is headquartered in Houston, Texas.